Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: Portugal Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20222
20233
20244
20259
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
AstraZeneca2
Bristol-Myers Squibb2
Eli Lilly and Company2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Mirati Therapeutics Inc.2
Amgen1
Boehringer Ingelheim1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung22
Lung Neoplasms7
Neoplasms4
Lung Diseases2
Bronchial Neoplasms1
Carcinoma1
Carcinoma, Bronchogenic1
Carcinoma, Hepatocellular1
Neoplasm Metastasis1
Neoplasms by Site1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.